cGMP signalling: From bench to bedside

EMBO Reports

Volumn 7, Issue 2, 2006, Pages 149-153

  Feil, Robert ^a   Kemp Harper, Barbara ^b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b MONASH UNIVERSITY   (Australia)

Author keywords

cGMP; Guanylyl cyclase; Nitric oxide; Protein kinase; Signal transduction

Indexed keywords

4 [[4 CARBOXYBUTYL[2 [(4 PHENETHYLBENZYL)OXY]PHENETHYL]AMINO]METHYL]BENZOIC ACID; 4 AMINO 5 CYCLOPROPYL 2 [1 (2 FLUOROBENZYL) 1H PYRAZOLO[3,4 B]PYRIDIN 3 YL]PYRIMIDINE; ATRIAL NATRIURETIC FACTOR; BAY 607550; BAY 736691; BRAIN NATRIURETIC PEPTIDE; CALCIUM ION; CARDIOVASCULAR AGENT; CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE; GUANYLATE CYCLASE; HMR 1766; NITRIC OXIDE; ORGANIC NITRATE; PHOSPHODIESTERASE; PHOSPHODIESTERASE INHIBITOR; SILDENAFIL; UNCLASSIFIED DRUG; VASODILATOR AGENT; PROTEIN KINASE;

ALZHEIMER DISEASE; ANGINA PECTORIS; ANGIOGENESIS; ATHEROSCLEROSIS; BLOOD PRESSURE REGULATION; BLOOD VESSEL TONE; CALCIUM TRANSPORT; CARDIOVASCULAR SYSTEM; CATALYSIS; CELL GROWTH; CENTRAL NERVOUS SYSTEM; COGNITIVE DEFECT; CONFERENCE PAPER; DRUG MECHANISM; ERECTILE DYSFUNCTION; HEART FAILURE; HUMAN; NONHUMAN; NUCLEOTIDE METABOLISM; PARTICULATE MATTER; PHENOTYPE; PRIORITY JOURNAL; PROTEIN HYDROLYSIS; PULMONARY HYPERTENSION; REGULATORY MECHANISM; RESTENOSIS; SIGNAL TRANSDUCTION; SOLUBILITY; ANIMAL; BIOLOGICAL MODEL; METABOLISM; ORGANIZATION;

ANIMALS; CONGRESSES; CYCLIC GMP; GUANYLATE CYCLASE; HUMANS; MODELS, BIOLOGICAL; NITRIC OXIDE; PROTEIN KINASES; SIGNAL TRANSDUCTION;

EID: 33645837833     PISSN: 1469221X     EISSN: 14693178     Source Type: Journal    
DOI: 10.1038/sj.embor.7400627     Document Type: Conference Paper

References (15)

1. Agullo L, Garcia-Dorado D, Escalona N, Ruiz-Means M, Mirabet M, Inserte J, Soler-Soler J (2005) Membrane association of nitric oxide-sensitive guanylyl cyclase in cardiomyocytes. Cardiovasc Res 68: 65-74
2. Beavo JA, Brunton LL (2002) Cyclic nucleotide research - still expanding after half a century. Nat Rev Mol Cell Biol 3: 710-718
3. Boon EM, Huang SH, Marletta MA (2005) A molecular basis for NO selectivity in soluble guanylate cyclase. Nat Chem Biol 1: 53-59
4. Deruelle P, Grover TR, Abman SH (2005) Pulmonary vascular effects of nitric oxide-cGMP augmentation in a model of chronic pulmonary hypertension in fetal and neonatal sheep. Am J Physiol Lung Cell Mol Physiol 289: L798-L806
5. Evgenov OV, Ichinose F, Evgenov NV, Gnoth MJ, Falkowski GE, Chang Y, Bloch KD, Zapol WM (2004) Soluble guanylate cyclase activator reverses acute pulmonary hypertension and augments the pulmonary vasodilator response to inhaled nitric oxide in awake lambs. Circulation 110: 2253-2259
6. Feil R, Lohmann SM, de Jonge H, Walter U, Hofmann F (2003) Cyclic GMP-dependent protein kinases and the cardiovascular system: Insights from genetically modified mice. Circ Res 93: 907-916
7. Friebe A, Koesling D (2003) Regulation of nitric oxide-sensitive guanylyl cyclase. Circ Res 93: 96-105
8. Geiselhöringer A et al. (2004) IRAG is essential for relaxation of receptor-triggered smooth muscle contraction by cGMP kinase. EMBO J 23: 4222-4231
9. Kuhn M (2003) Structure, regulation, and function of mammalian membrane guanylyl cyclase receptors, with a focus on guanylyl cyclase-A. Circ Res 93: 700-709
10. Massberg S et al. (2004) Enhanced in vivo platelet adhesion in vasodilator-stimulated phosphoprotein (VASP)-deficient mice. Blood 103: 136-142
11. McKie PM, Burnett JC, Jr (2005) B-type natriuretic peptide as a biomarker beyond heart failure: Speculations and opportunities. Mayo Clin Proc 80: 1029-1036
12. Rybalkin SD, Van C, Bornfeldt KE, Beavo JA (2003) Cyclic GMP phosphodiesterases and regulation of smooth muscle function. Circ Res 93: 280-291
13. Sabrane K, Kruse MN, Fabritz L, Zetsche B, Mitko D, Skryabin BV, Zwiener M, Baba HA, Yanagisawa M, Kuhn M (2005) Vascular endothelium is critically involved in the hypotensive and hypovolemic actions of atrial natriuretic peptide. J Clin Invest 115: 1666-1674
14. Schmidt PM, Schramm M, Schroder H, Wunder F, Stasch JP (2004) Identification of residues crucially involved in the binding of the haem moiety of soluble guanylate cyclase. J Biol Chem 279: 3025-3032
15. Takimoto E, Champion HC, Li M, Belardi D, Ren S, Rodriguez ER, Bedja D, Gabrielson KL, Wang Y, Kass DA (2005) Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy. Nat Med 11: 214-222